| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.005 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.092 | 0.006 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.099 | 0.008 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.008 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.094 | 0.008 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.35 | 0.008 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.096 | 0.009 |